Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells.

CRISPR/Cas9 differentiated thyroid carcinoma (DTC) functional polymorphism rs4644 galectin-3 (gal3) papillary thyroid carcinoma (PTC) proteome

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2024
Historique:
received: 01 02 2024
accepted: 22 05 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

The single nucleotide polymorphism (SNP) rs4644 at codon 64 of galectin-3 (gal-3, gene name: To deepen our understanding of the biological effects of this SNP, we analyzed the proteome of two isogenic cell lines (NC-P64 vs. NA-H64) derived from the immortalized non-malignant thyrocyte cell line Nthy-Ori, generated through the CRISPR-Cas9 technique to differ by rs4644 genotype. We compared the proteome of these cells to detect differentially expressed proteins and studied their proteome in relation to their transcriptome. Firstly, we found, consistently with previous studies, that gal-3-H64 could be detected as a monomer, homodimer, and heterodimer composed of one cleaved and one uncleaved monomer, whereas gal-3-P64 could be found only as a monomer or uncleaved homodimer. Moreover, results indicate that rs4644 influences the expression of several proteins, predominantly upregulated in NA-H64 cells. Overall, the differential protein expression could be attributed to the altered mRNA expression, suggesting that rs4644 shapes the function of gal-3 as a transcriptional co-regulator. However, this SNP also appeared to affect post-transcriptional regulatory mechanisms for proteins whose expression was oppositely regulated compared to mRNA expression. It is conceivable that the rs4644-dependent activities of gal-3 could be ascribed to the different modalities of self-dimerization. Our study provided further evidence that rs4644 could affect the gal-3 functions through several routes, which could be at the base of differential susceptibility to diseases, as reported in case-control association studies.

Identifiants

pubmed: 38933925
doi: 10.3389/fgene.2024.1380495
pii: 1380495
pmc: PMC11199678
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1380495

Informations de copyright

Copyright © 2024 Silvestri, Zallocco, Corrado, Ronci, Aceto, Ricci, Cipollini, Dell’Anno, De Simone, De Marco, Ferrarini, Beghelli, Mazzoni, Lucacchini, Gemignani, Giusti and Landi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Roberto Silvestri (R)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Lorenzo Zallocco (L)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Alda Corrado (A)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Maurizio Ronci (M)

Department of Medical, Oral and Biotechnological Sciences, University "G.D'Annunzio" of Chieti-Pescara, Chieti, Italy.
COIIM, Interuniversitary Consortium for Engineering and Medicine, Campobasso, Italy.

Romina Aceto (R)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Benedetta Ricci (B)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Monica Cipollini (M)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Irene Dell'Anno (I)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Chiara De Simone (C)

Department of Medical, Oral and Biotechnological Sciences, University "G.D'Annunzio" of Chieti-Pescara, Chieti, Italy.

Giuseppina De Marco (G)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Eleonora Ferrarini (E)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Daniela Beghelli (D)

School of Biosciences and Veterinary Medicine, Via Gentile III da Varano, University of Camerino, Camerino, Italy.

Maria Rosa Mazzoni (MR)

Department of Pharmacy, University of Pisa, Pisa, Italy.

Antonio Lucacchini (A)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Federica Gemignani (F)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Laura Giusti (L)

School of Pharmacy, University of Camerino, Camerino, Italy.

Stefano Landi (S)

Department of Biology, Genetic Unit, University of Pisa, Pisa, Italy.

Classifications MeSH